A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture
NCT02402829 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2021-01-06
Summary
The purpose of this research study is to see if factor levels and inhibitor levels in Hemophilia A and B subjects are accurate when they are drawn from a central venous line (CVL) instead of from a peripheral stick.
Conditions
- Hemophilia A
- Factor VIII Deficiency
- Hemophilia
- Hemophilia B
- Factor IX Deficiency
Interventions
- PROCEDURE
-
Peripheral Vein Blood draw
Drawing blood through a peripheral vein in the arm.
Sponsors & Collaborators
-
Children's Mercy Hospital Kansas City
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 21 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2018-11-28
- Completion
- 2018-11-28
Countries
- United States
Study Locations
More Related Trials
-
Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
NCT02324517 ·Status: UNKNOWN
-
The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B
NCT03623295 ·Status: COMPLETED
-
Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?
NCT02803502 ·Status: UNKNOWN ·Phase: NA
-
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
NCT02207894 ·Status: RECRUITING
-
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
NCT02225483 ·Status: COMPLETED
-
Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
NCT02971930 ·Status: COMPLETED
-
Thrombin Generation Numerical Models Validation in Haemophilic Case
NCT02300519 ·Status: COMPLETED
-
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
NCT02540187 ·Status: COMPLETED
-
Cooperative Study of Factor VIII Inhibitors
NCT00000582 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
NCT04060836 ·Status: UNKNOWN ·Phase: PHASE1
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A
NCT02930317 ·Status: UNKNOWN ·Phase: PHASE3
-
Low VW Activity in Adolescent HMB
NCT02933411 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
NCT05568719 ·Status: RECRUITING ·Phase: PHASE3
-
Hemophilia Inhibitor Previously Untreated Patient Study
NCT01652027 ·Status: COMPLETED
-
Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage
NCT00770718 ·Status: TERMINATED ·Phase: PHASE1
-
Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients
NCT06938659 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa
NCT01856751 ·Status: UNKNOWN
-
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
NCT05022459 ·Status: RECRUITING
-
Are There Differences Between Carriers of Haemophilia A and B?
NCT05217992 ·Status: COMPLETED
-
Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B
NCT00922792 ·Status: COMPLETED ·Phase: PHASE1
-
Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B
NCT06634836 ·Status: WITHDRAWN
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography
NCT03002480 ·Status: WITHDRAWN ·Phase: NA